|
(CRCL) vaccine for Chronic Myelogenous Leukemia
|
5R01CA104926-04
|
$264,158
|
KATSANIS, EMMANUEL
|
UNIVERSITY OF ARIZONA
|
|
2007 Gordon Research Conference- Cancer and Stem Cells
|
1R13CA130652-01
|
$10,000
|
CLARKE, MICHAEL
|
STANFORD UNIVERSITY
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
5R01CA121180-02
|
$266,661
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-02
|
$309,600
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
A Genome-Wide Association Study of Non-Hodgkin Lymphoma
|
5R01CA122663-02
|
$557,175
|
Skibola, Christine
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
1R01CA120381-01A1
|
$369,962
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
|
5R01CA107300-04
|
$270,281
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
|
1R01CA129974-01A1
|
$324,900
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INSTITUTE
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
2R01CA055577-14
|
$264,061
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-02
|
$254,392
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
AbI-Abi signaling in neoplastic hematopoiesis
|
5R01CA094921-06
|
$243,183
|
DAI, ZONGHAN
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
Aplan, Peter
|
CCR (NCI)
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
3R01CA105255-04S1
|
$54,505
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
5R01CA105255-04
|
$262,919
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
Alpha-Particle Immunotherapy of Cancer
|
5R01CA055349-15
|
$389,561
|
SCHEINBERG, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Alternative Entry Mechanism for Pathogenic Retroviruses
|
5R01CA104266-04
|
$259,594
|
CUNNINGHAM, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An Ets2 dependent stromal restriction of breast cancer
|
5R01CA098778-05
|
$324,050
|
OSHIMA, ROBERT
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Analysis of a murine model of the AML1-ETO translocation
|
5R01CA096798-04
|
$281,848
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Analysis of CD8 T cell responses to tumors
|
5R01CA071833-10
|
$282,084
|
DUTTON, RICHARD
|
TRUDEAU INSTITUTE, INC.
|
|
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS
|
5R01CA100933-04
|
$296,523
|
MITTAL, VIVEK
|
COLD SPRING HARBOR LABORATORY
|
|
Analysis of Intracellular Drug Sequestration
|
5R01CA106655-03
|
$205,489
|
KRISE, JEFFREY
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Analysis of p53 in vivo using unique mouse model
|
5R01CA100193-05
|
$317,323
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Analysis of PU.1 Function in Hematopoiesis
|
5R01CA072769-11
|
$291,787
|
Scott, Edward
|
UNIVERSITY OF FLORIDA
|
|
Angiogenesis in Breast Cancer
|
5R01CA106263-03
|
$318,352
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-02
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS
|
5R01CA077357-09
|
$303,039
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Anti-TfR IgG3-Av: A New Drug Against Multiple Myeloma
|
5R01CA107023-03
|
$300,313
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anti-Tumor immunity in myeloma
|
5R01CA106802-04
|
$328,499
|
DHODAPKAR, MADHAV
|
ROCKEFELLER UNIVERSITY
|
|
Antibodies with Infinite Affinity
|
5R01CA016861-31
|
$277,428
|
MEARES, CLAUDE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Antibody V Gene Expression B Cell Lymphocytic Leukemia
|
5R37CA049870-20
|
$329,612
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Antigen Presenting Cells in the Induction of GVHD
|
5R01CA102464-04
|
$277,278
|
EMERSON, STEPHEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
|
5R01CA119903-03
|
$74,470
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-21
|
$360,308
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-02
|
$256,507
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy
|
1R41CA121665-01A2
|
$328,300
|
Shirwan, Haval
|
APOIMMUNE, INC
|
|
Application of SEREX antigen in multiple myeloma
|
5R01CA088434-10
|
$242,114
|
Lim, Seah
|
HARRINGTON REGIONAL MEDICAL CENTER, INC.
|
|
Arginine Regulates T Cell Signal Transduction & Function
|
3R01CA082689-08S1
|
$201,658
|
OCHOA, AUGUSTO
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Arsenic Trioxide Activaed Pathways in APL
|
5R01CA121192-02
|
$260,253
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY
|
|
Aspartame Intake and the Risk of Cancer
|
1R03CA130054-01
|
$116,101
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Aspirin/Folate Prevention of Large Bowel Polyps
|
5R01CA059005-14
|
$605,742
|
BARON, JOHN
|
DARTMOUTH COLLEGE
|
|
Assays for Screening Histone Modification in Cancer
|
5R01CA107106-04
|
$223,262
|
FREITAS, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Assessment of Clinical Retinoid Activity in Leukemia
|
5R01CA056771-15
|
$379,637
|
GALLAGHER, ROBERT
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Astatine-211 Conditioning for Nonmyeloablative Hematopoietic Stem Cell Allografts
|
5R01CA118940-02
|
$273,434
|
SANDMAIER, BRENDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Progenitors
|
1R41CA126604-01
|
$300,000
|
Christensen, Julie
|
CELLERANT THERAPEUTICS, INC.
|
|
BAALC in neurogenesis and hematopoiesis
|
5R01CA098933-04
|
$290,595
|
DE LA CHAPELLE, ALBERT
|
OHIO STATE UNIVERSITY
|
|
Bcl-2 family and redox control of genomic instability
|
5R01CA104695-04
|
$229,365
|
Knudson, C
|
UNIVERSITY OF IOWA
|
|
Bcl-2 selective inhibitors: development and application to cancer treatment
|
5R01CA114294-02
|
$203,470
|
XING, CHENGGUO
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
BCMA: Controlling the survival of differentiated B cells
|
5R01CA108896-04
|
$248,647
|
NOELLE, RANDOLPH
|
DARTMOUTH COLLEGE
|
|
Biochemical and Genetic Studies of Latent Membrane Pro 2
|
5R01CA062234-14
|
$264,713
|
Longnecker, Richard
|
NORTHWESTERN UNIVERSITY
|
|
Biochemistry of Leukemia Virus Core Binding Factor
|
5R01CA058343-14
|
$405,444
|
SPECK, NANCY
|
DARTMOUTH COLLEGE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|